Cite
Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
MLA
De Brakeleer, S., et al. “Frequent Incidence of BARD1-Truncating Mutations in Germline DNA from Triple-Negative Breast Cancer Patients.” Clinical Genetics, vol. 89, no. 3, Mar. 2016, pp. 336–40. EBSCOhost, https://doi.org/10.1111/cge.12620.
APA
De Brakeleer, S., De Grève, J., Desmedt, C., Joris, S., Sotiriou, C., Piccart, M., Pauwels, I., & Teugels, E. (2016). Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients. Clinical Genetics, 89(3), 336–340. https://doi.org/10.1111/cge.12620
Chicago
De Brakeleer, S., J. De Grève, C. Desmedt, S. Joris, C. Sotiriou, M. Piccart, I. Pauwels, and E. Teugels. 2016. “Frequent Incidence of BARD1-Truncating Mutations in Germline DNA from Triple-Negative Breast Cancer Patients.” Clinical Genetics 89 (3): 336–40. doi:10.1111/cge.12620.